Literature DB >> 28727615

Multiplexing Prisms for Field Expansion.

Eli Peli1, Jae-Hyun Jung.   

Abstract

PURPOSE: Prisms used for field expansion are limited by the optical scotoma at a prism apex (apical scotoma). For a patient with two functioning eyes, fitting prisms unilaterally allows the other eye to compensate for the apical scotoma. A monocular patient's field loss cannot be expanded with a conventional or Fresnel prism because of the apical scotoma. A newly invented optical device, the multiplexing prism (MxP), was developed to overcome the apical scotoma limitation in monocular field expansion.
METHODS: A Fresnel-prism-like device with alternating prism and flat elements superimposes shifted and see-through views, thus creating the (monocular) visual confusion required for field expansion and eliminating the apical scotoma. Several implementations are demonstrated and preliminarily evaluated for different monocular conditions with visual field loss. The field expansion of the MxP is compared with the effect of conventional prisms using calculated and measured perimetry.
RESULTS: Field expansion without apical scotomas is shown to be effective for monocular patients with hemianopia or constricted peripheral field. The MxPs are shown to increase the nasal field for a patient with only one eye and for patients with bitemporal hemianopia. The MxPs placed at the far temporal field are shown to expand the normal visual field. The ability to control the contrast ratio between the two images is verified.
CONCLUSIONS: A novel optical device is demonstrated to have the potential for field expansion technology in a variety of conditions. The devices may be inexpensive and can be constructed in a cosmetically acceptable format.

Entities:  

Mesh:

Year:  2017        PMID: 28727615      PMCID: PMC5542858          DOI: 10.1097/OPX.0000000000001102

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  23 in total

1.  Dynamic visual fields of one-eyed observers.

Authors:  Gregory W Good; Nicklaus Fogt; Kent M Daum; G Lynn Mitchell
Journal:  Optometry       Date:  2005-05

2.  DLP-based dichoptic vision test system.

Authors:  Russell L Woods; Henry L Apfelbaum; Eli Peli
Journal:  J Biomed Opt       Date:  2010 Jan-Feb       Impact factor: 3.170

3.  Binocular rivalry with peripheral prisms used for hemianopia rehabilitation.

Authors:  Andrew M Haun; Eli Peli
Journal:  Ophthalmic Physiol Opt       Date:  2014-09       Impact factor: 3.117

4.  Peripheral prism glasses: effects of moving and stationary backgrounds.

Authors:  Jieming Shen; Eli Peli; Alex R Bowers
Journal:  Optom Vis Sci       Date:  2015-04       Impact factor: 1.973

5.  Prism therapy and visual rehabilitation in homonymous visual field loss.

Authors:  Evelyn C O'Neill; Paul P Connell; Jeremy C O'Connor; Janice Brady; Irene Reid; Patricia Logan
Journal:  Optom Vis Sci       Date:  2011-02       Impact factor: 1.973

6.  Field expansion for homonymous hemianopia by optically induced peripheral exotropia.

Authors:  E Peli
Journal:  Optom Vis Sci       Date:  2000-09       Impact factor: 1.973

7.  The role of peripheral vision in saccade planning: learning from people with tunnel vision.

Authors:  Gang Luo; Fernando Vargas-Martin; Eli Peli
Journal:  J Vis       Date:  2008-12-22       Impact factor: 2.240

8.  Peripheral prism glasses: effects of dominance, suppression, and background.

Authors:  Nicole C Ross; Alex R Bowers; Eli Peli
Journal:  Optom Vis Sci       Date:  2012-09       Impact factor: 1.973

9.  Inattentional blindness and augmented-vision displays: effects of cartoon-like filtering and attended scene.

Authors:  Henry L Apfelbaum; Doris H Apfelbaum; Russell L Woods; Eli Peli
Journal:  Ophthalmic Physiol Opt       Date:  2008-05       Impact factor: 3.117

10.  Community-based trial of a peripheral prism visual field expansion device for hemianopia.

Authors:  Alex R Bowers; Karen Keeney; Eli Peli
Journal:  Arch Ophthalmol       Date:  2008-05
View more
  9 in total

1.  Field Expansion for Acquired Monocular Vision Using a Multiplexing Prism.

Authors:  Jae-Hyun Jung; Eli Peli
Journal:  Optom Vis Sci       Date:  2018-09       Impact factor: 1.973

2.  Low Vision Enhancement with Head-mounted Video Display Systems: Are We There Yet?

Authors:  Ashley D Deemer; Christopher K Bradley; Nicole C Ross; Danielle M Natale; Rath Itthipanichpong; Frank S Werblin; Robert W Massof
Journal:  Optom Vis Sci       Date:  2018-09       Impact factor: 1.973

3.  Peripheral Prisms Improve Obstacle Detection during Simulated Walking for Patients with Left Hemispatial Neglect and Hemianopia.

Authors:  Kevin E Houston; Alex R Bowers; Eli Peli; Russell L Woods
Journal:  Optom Vis Sci       Date:  2018-09       Impact factor: 1.973

4.  No Useful Field Expansion with Full-field Prisms.

Authors:  Jae-Hyun Jung; Eli Peli
Journal:  Optom Vis Sci       Date:  2018-09       Impact factor: 1.973

5.  Measuring Pedestrian Collision Detection With Peripheral Field Loss and the Impact of Peripheral Prisms.

Authors:  Cheng Qiu; Jae-Hyun Jung; Merve Tuccar-Burak; Lauren Spano; Robert Goldstein; Eli Peli
Journal:  Transl Vis Sci Technol       Date:  2018-09-04       Impact factor: 3.283

6.  Psychophysical Tests Do Not Identify Ocular Dominance Consistently.

Authors:  Miguel A García-Pérez; Eli Peli
Journal:  Iperception       Date:  2019-04-29

7.  Photographic Depiction of the Field of View with Spectacles-mounted Low Vision Aids.

Authors:  Jae-Hyun Jung; Nish Mohith Kurukuti; Eli Peli
Journal:  Optom Vis Sci       Date:  2021-10-01       Impact factor: 1.973

8.  2017 Charles F. Prentice Award Lecture: Peripheral Prisms for Visual Field Expansion: A Translational Journey.

Authors:  Eli Peli
Journal:  Optom Vis Sci       Date:  2020-10       Impact factor: 2.106

9.  Field Expansion with Multiplexing Prism Glasses Improves Pedestrian Detection for Acquired Monocular Vision.

Authors:  Jae-Hyun Jung; Rachel Castle; Nish Mohith Kurukuti; Sailaja Manda; Eli Peli
Journal:  Transl Vis Sci Technol       Date:  2020-07-23       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.